InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America. For more information, visit: http://www.intercure.co.
| Website | http://www.intercure.co |
| Employees | 22 (12 on RocketReach) |
| Founded | 2008 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Cannabis Cultivation, Cannabis Production, Medical Cannabis, Pharmaceutical Cannabis, Cannabis Distribution, Global Cannabis, Cannabis Research, Cannabis Export, Cannabis Extraction, Cbd Products, Cannabis Technology, Cannabis Market, Cannabis Edibles, Cannabis Investment, Plant-Based Medicine, Healthcare Solutions, Cannabis Topicals, Alternative Medicine, Natural Remedies |
| Competitors | Trulieve, Curaleaf, Cresco Labs, Green Thumb Industries (GTI), Tilray Brands, Inc., Canopy Growth Corporation, Organigram Inc, MedMen, Columbia Care Center, Hexo +26 more (view full list) |
Looking for a particular INTERCURE employee's phone or email?
Amos Cohen is the CFO of INTERCURE.
12 people are employed at INTERCURE.
INTERCURE is based in Herzliya, Tel Aviv District.